Question for oral answer (O-000088/2018) by Alojz Peterle, Daciana Octavia Sârbu, Jadwiga Wiśniewska, Frédérique Ries, Merja Kyllönen, Michèle Rivasi, Mireille D'Ornano and Sylvie Goddyn, on behalf of the ENVI Committee, to the Commission: Lyme disease (borreliosis) (B8-0417/2018) (2018/2774(RSP))
Merja Kyllönen moved the question.
Věra Jourová (Member of the Commission) answered the question.
The following spoke: Alojz Peterle, on behalf of the PPE Group, Karin Kadenbach, on behalf of the S&D Group, Jadwiga Wiśniewska, on behalf of the ECR Group, Frédérique Ries, on behalf of the ALDE Group, Michèle Rivasi, on behalf of the Verts/ALE Group, Mireille D'Ornano, on behalf of the EFDD Group, Dominique Bilde, on behalf of the ENF Group, Françoise Grossetête, Tilly Metz, Sylvie Goddyn, Annie Schreijer-Pierik, Claudiu Ciprian Tănăsescu, John Stuart Agnew and Mairead McGuinness.
The following spoke under the catch-the-eye procedure: Notis Marias and Seán Kelly.
IN THE CHAIR: Dimitrios PAPADIMOULIS Vice-President
The following spoke under the catch-the-eye procedure: Linnéa Engström, Bogdan Andrzej Zdrojewski, Kateřina Konečná, Marian Harkin and Dubravka Šuica.
The following spoke: Věra Jourová
Motion for a resolution to wind up the debate tabled under Rule 128(5):
— Alojz Peterle, Daciana Octavia Sârbu, Jadwiga Wiśniewska, Frédérique Ries, Merja Kyllönen, Michèle Rivasi, Mireille D’Ornano and Sylvie Goddyn, on behalf of the ENVI Committee, on Lyme disease (Borreliosis) (2018/2774(RSP)) (B8-0514/2018).